Intensity of end-of-life care for gynecologic cancer patients by primary oncologist specialty

Abstract

ObjectiveThe association of primary oncologist specialty, medical oncology versus gynecologic oncology, on intensity of care at the end of life in elderly patients with gynecologic cancer is unclear.MethodsThis retrospective cohort study used Surveillance, Epidemiology and End Results-Medicare (SEER-M) data. Subjects were fee-for-service Medicare enrollees aged 65 years and older who died of a gynecologic cancer between January 2006 and December 2015. The primary outcome was a composite score for high-intensity care received in the last month of life. Secondary outcomes included invasive procedures and Medicare spending in the last month of life. Simple and multivariable linear and logistic regression analyses evaluated differences in outcomes by primary oncologist specialty. Linear regressions were repeated after creating a more similar control group through nearest-neighbor propensity score matching.ResultsOf 12 189 patients, 7705 (63%) had a medical primary oncologist in the last year of life. In adjusted analyses, patients with a gynecologic versus medical primary oncologist received lower rates of high-intensity end-of-life care (53.9% vs 56.6%; p=0.018). Results were similar for the propensity score-matched cohorts. However, having a gynecologic versus medical primary oncologist was associated with higher rates of invasive procedures in the last month of life (43% vs 41%; p=0.014) and higher Medicare spending ($83 859 vs $74 849; p=0.004).ConclusionsBoth specialties engage in overall high levels of intense end-of-life care, with differences by specialty in aspects of aggressive care and spending at the end of life. Physician-level training could be a target for educational or quality improvement initiatives to improve end-of-life cancer care delivery.

Palliative Medicine Referral and End-of-Life Interventions Among Racial and Ethnic Minority Patients With Advanced or Recurrent Gynecologic Cancer

“…These factors were identified and selected based on published studies evaluating patients with cancer, including gynecologic malignancies. [12][13][14] Figure 1. Inclusion and exclusion criteria.…”

End-of-life care quality metrics in patients with cancer: challenges and opportunities

“… Hicks-Courant et al have authored an important article on use of aggressive interventions among Medicare patients 65 years or older with gynecological malignancies. The authors used the Surveillance, Epidemiology, and End Results (SEER) database to determine the frequency, intensity, and overall cost of care 2. One key finding is that more than half of the patients received aggressive care, with more than 40% having received invasive procedures during the last month of life.…”